|
|
|
|
|
Product Name
|
INO80 antibody
|
|
Product type
|
Primary antibodies
|
|
Description
|
Mouse polyclonal to INO80
|
|
Immunogen
|
Fusion protein: MDPSRETFDG STRDSYKPPN GAEMMGQSEL NTQNRIPYNT SANNRNWQIP LYWQQRGNEF QASPPPPLGY VTPEYGATGT PVNANNASRV DYATTAANVP corresponding to amino acids 1/100 of Schizosaccharomyces pombe INO80 BLAST 'MDPSRETFDG STRDSYKPPN GAEMMGQSEL NTQNRIPYNT SANNRNWQIP LYWQQRGNEF QASPPPPLGY VTPEYGATGT PVNANNASRV DYATTAANVP ' with or 
|
|
Reacts with
(species key)
|
S pom
|
|
Tested applications
(see key)
|
WB
|
|
|
Abreviews
|
|
|
|
Application notes
(see key)
|
Recommended dilutions WB: 1/1000. Predicted molecular weight: 192 kDa. Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user. This antibody has been tested in Western blot against an E.coli lysate containing the partial recombinant fusion protein used as an immunogen. We have no data on detection of endogenous protein.
|
|
Cellular localization
|
Nuclear
|
|
Research areas
|
Chromatin and Nuclear Signaling >> Chromatin Remodeling >> INO80
|
|
Relevance
|
INO80 chromatin remodeling complex is evolutionarily conserved and directly participates in the repair of a double-strand break (DSB) in yeast. INOC1/INO80 is the human homolog of S. cerevisiae INO80, the catalytic ATPase subunit of the INO80 chromatin remodeling complex. INO80/INOC1 defines a subfamily of SWI2/SNF2 chromatin remodeling proteins.
This antibody was raised by a genetic immunization technique. Genetic immunization can be used to generate antibodies by directly delivering antigen-coding DNA into the animal, rather than injecting a protein or peptide (Tang et al. PubMed: 1545867; Chambers and Johnston PubMed: 12910245; Barry and Johnston PubMed: 9234514). The animal`s cells produce the protein, which stimulates the animal`s immune system to produce antibodies against that particular protein.
A vector coding for a partial fusion protein was used for genetic immunisation of a mouse and the resulting serum was tested in Western blot against an E.coli lysate containing that partial fusion protein.
Genetic immunization offers enormous advantages over the traditional protein-based immunization method. DNA is faster, cheaper and easier to produce and can be produced by standard techniques readily amenable to automation. Furthermore, the antibodies generated by genetic immunization are usually of superior quality with regard to specificity, affinity and recognizing the native protein.
|
|
|
|
|
Raised in
|
Mouse
|
|
Clonality
|
Polyclonal
|
|
Isotype
|
IgG
|
|
Purity
|
Whole antiserum
|
|
Storage buffer
|
Constituents: 50% Glycerol Material safety datasheet (MSDS) for this product: Glycerol MSDS
|
|
Form
|
Liquid
|
|
Concentration
|
Concentration not determined - why is this?
|
|
Storage instructions
|
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.
|
|
Notes
|
Produced from outbred CD1 mice
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this INO80 antibody is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
| |
|
Search PubMed (MEDLINE) for references to INO80
|
| |
INO80 antibody - more information
|
Customer reviews (feedback) regarding INO80 antibody |
Customer FAQs regarding INO80 antibody |
Protocols for INO80 antibody |
Price and availability of products related to INO80 antibody |
| |
INO80 antibody - related products:
|
|
|
| |
INO80 antibody - other tools:
|
Contact Abcam with a Technical Enquiry about INO80 antibody |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"